Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Bay 11-7085 has been used as: nuclear factor-κB inhibitor in Panc-1 cells, macrophages inhibitory κB kinase IKK inhibitor in human astrocytoma cells U87MGs phospho-p65 inhibitor human monocyte cell line THP-1

Biochem/physiol Actions

Bay 11-7085 inactivates peroxisome proliferator-activated receptors γ (PPAR-γ) and increases the microtubule-associated proteins 1A/1B light chain 3B (LC3B), a marker of autophagy resulting in apoptosis in human synovial fibroblasts. It promotes apoptosis in pancreatic carcinoma and may serve as radiotherapy-sensitizing drug. BAY 11-7085 decreases B-cell lymphoma 2 (Bcl-2) by inhibiting pI-κBα (inhibitor of nuclear factor κ B kinase subunit α

Inhibits NF-κB activated expression of ICAM-1, VCAM-1, E-selectin, IL-6 and IL-8.

Packaging

10 mg in glass bottle